Braun Stacey Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-38,262
| Closed | -$5.85M | – | 145 |
|
|
2021
Q1 | $5.85M | Sell |
38,262
-82,940
| -68% | -$12.7M | 0.25% | 103 |
|
|
2020
Q4 | $18.9M | Buy |
121,202
+10,434
| +9% | +$1.63M | 0.85% | 52 |
|
|
2020
Q3 | $12.7M | Sell |
110,768
-2,157
| -2% | -$247K | 0.68% | 75 |
|
|
2020
Q2 | $12.7M | Buy |
112,925
+144
| +0.1% | +$16.2K | 0.73% | 72 |
|
|
2020
Q1 | $10.1M | Sell |
112,781
-31,580
| -22% | -$2.84M | 0.77% | 63 |
|
|
2019
Q4 | $15.6M | Buy |
144,361
+19,250
| +15% | +$2.08M | 0.87% | 59 |
|
|
2019
Q3 | $12.3M | Buy |
125,111
+6,361
| +5% | +$623K | 0.77% | 75 |
|
|
2019
Q2 | $15.6M | Buy |
118,750
+4,040
| +4% | +$529K | 1% | 43 |
|
|
2019
Q1 | $15.5M | Buy |
114,710
+19,600
| +21% | +$2.65M | 1.03% | 39 |
|
|
2018
Q4 | $9.26M | Sell |
95,110
-18,962
| -17% | -$1.85M | 0.73% | 68 |
|
|
2018
Q3 | $15.9M | Buy |
114,072
+7,243
| +7% | +$1.01M | 1.01% | 41 |
|
|
2018
Q2 | $13.3M | Buy |
106,829
+5,771
| +6% | +$716K | 0.9% | 55 |
|
|
2018
Q1 | $11.3M | Buy |
+101,058
| New | +$11.3M | 0.77% | 73 |
|
|
2015
Q3 | – | Sell |
-101,600
| Closed | -$18.4M | – | 279 |
|
|
2015
Q2 | $18.4M | Buy |
+101,600
| New | +$18.4M | 0.78% | 56 |
|
|
2013
Q4 | – | Sell |
-2,080
| Closed | -$242K | – | 162 |
|
|
2013
Q3 | $242K | Sell |
2,080
-21,090
| -91% | -$2.45M | 0.01% | 133 |
|
|
2013
Q2 | $2.14M | Buy |
+23,170
| New | +$2.14M | 0.13% | 108 |
|